Ratings Moves: MGM,...
Health Care: Drugs
Optimer Pharmaceuticals Inc. (OPTR: NASDAQ)
$14.67 0.29 | 2.02%
05/23/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| OPTR | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 28.95 | -7.05 | 31.90 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | -30.00 | 112.74 | 3.77 |
| Net Income | -100.00 | -0.12 | 0.00 |
| EPS | -100.00 | -0.40 | 0.00 |
Earnings for OPTR:
| EBITDA | -89.00 |
| REVENUE | 101.53M |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.60 | $-0.50 | $-2.17 | $-1.07 |
| Number of Analysts | 7 | 6 | 9 | 8 |
| High Estimate | $-0.52 | $-0.42 | $-1.95 | $-0.56 |
| Low Estimate | $-0.69 | $-0.58 | $-2.38 | $-1.43 |
| Prior Year | $-0.01 | $-0.56 | $-1.51 | $-2.17 |
| Growth Rate (Year over Year) | -5,871.43% | 10.12% | -43.64% | 50.49% |
Portfolios with OPTR
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
Latest OPTR Headlines from TheStreet
- Cubist, Optimer, Trius: Antibiotic Deal Making On Tap 05.22.13 | 07:05 am
- 3 Biotech Stocks Spiking With Big Volume 05.13.13 | 02:05 pm
- 3 Biotech Stocks Rising on Big Volume 02.27.13 | 02:02 pm
- 10 Biotech Stocks With A History Of Beating Earning Expectations 01.10.13 | 07:01 pm
- 5 Biotech Stocks Rising on Unusual Volume 11.20.12 | 02:11 pm
- 5 Stocks Moving Higher on Big Volume 09.04.12 | 02:09 pm
- Optimer Pharmaceuticals Management Discusses Q2 2012 Results - Earnings Call Transcript 07.31.12 | 10:07 pm
- Optimer Pharmaceuticals Inc. Stock Downgraded (OPTR) 05.17.12 | 05:05 am
- 5 Earnings Stocks Poised to Pop 05.09.12 | 10:05 am
- 7 Stocks Spiking on Unusual Volume 04.25.12 | 01:04 pm
Press Releases for OPTR
- Optimer Pharmaceuticals Appoints Eric Sirota As Chief Operating Officer - PR Newswire 05.13.13 | 04:05 pm
- Optimer Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results - PR Newswire 05.02.13 | 08:05 am
- DIFICID® (fidaxomicin) Tablets Approved In Australia - PR Newswire 04.26.13 | 08:04 am
- Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire 03.15.13 | 08:03 am
- Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire 02.27.13 | 08:02 am
- Optimer Pharmaceuticals' Board Of Directors Appoints Board Chairman, Dr. Henry McKinnell, Chief Executive Officer - PR Newswire 02.27.13 | 08:02 am
- New Analysis Shows Age Has A Significant Effect On Outcomes In Patients Being Treated For Clostridium Difficile Infection (CDI) - PR Newswire 02.14.13 | 08:02 am
- Optimer Pharmaceuticals To Host Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year 2012 Financial Results - PR Newswire 02.07.13 | 08:02 am
- Optimer Pharmaceuticals To Present At Leerink Swann Global Healthcare Conference - PR Newswire 02.07.13 | 08:02 am
- Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - PR Newswire 02.01.13 | 08:02 am
Partner Headlines for OPTR
- Narrower Loss at Optimer - Analyst Blog - Zacks 11.02.12 | 05:11 pm
- Pipeline Progress at Cubist Pharma - Analyst Blog - Zacks 11.01.12 | 06:11 pm
- Earnings Preview: Cubist Pharma - Analyst Blog - Zacks 10.17.12 | 09:10 am
- Optimer Pharma to Sell Optimer Bio Stake - Analyst Blog - Zacks 10.09.12 | 07:10 pm
- UPDATE: Oppenheimer Downgrades Optimer Pharmaceuticals to Perform on Near-Term Outlook - Benzinga 10.09.12 | 01:10 pm
- UPDATE: Morgan Stanley Initiates Optimer Pharmaceuticals at Underweight on Risk/Reward - Benzinga 10.04.12 | 01:10 pm
- How one bull is playing Optimer Pharma - NASDAQ 09.11.12 | 09:09 am
- Optimer's Dificid OK'd in Canada - Analyst Blog - Zacks 07.09.12 | 07:07 pm
- Optimer Earns Milestone Payment - Analyst Blog - Zacks 06.08.12 | 04:06 pm
- UPDATE: Ladenburg Thalmann Maintains Buy Rating, Raises PT for Optimer Pharmaceuticals - Benzinga 05.11.12 | 09:05 am
